We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Vir Biotechnology Inc
43 own
13 watching
Current Price
$11.2
$0.67
(6.36%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,049.39M
52-Week High
14.45000
52-Week Low
6.56000
Average Volume
1.98M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,049.39M52-Week High14.4500052-Week Low6.56000Average Volume1.98MDividend Yield--P/E Ratio--What does the Vir Biotechnology Inc do?
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Read More
How much money does Vir Biotechnology Inc make?
News & Events about Vir Biotechnology Inc.
Globe Newswire
1 year ago
SAN FRANCISCO, June 29, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, effective July 10, 2023. Ms. Damouni Ellis will be responsible for the Companys strategic ...
Ticker Report
1 year ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 9,902 shares of the firms stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $25.18, for a total transaction of $249,332.36. Following ...
PR Newswire
1 year ago
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL Congress 2023 Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL Congress 2023 PR Newswire DURHAM, N.C. and BEIJING, June 25, 2023 Late-breaking data from...
Globe Newswire
1 year ago
Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator can achieve rapid and deep declines in hepatitis B virus surface antigen (HBsAg) and higher rates of HBsAg loss compared to antivirals or ...
Ticker Report
1 year ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) has been given a consensus rating of Moderate Buy by the eight analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating...
Frequently Asked Questions
Frequently Asked Questions
What is Vir Biotechnology Inc share price today?
Can Indians buy Vir Biotechnology Inc shares?
How can I buy Vir Biotechnology Inc shares from India?
Can Fractional shares of Vir Biotechnology Inc be purchased?
What are the documents required to start investing in Vir Biotechnology Inc stocks?
What is today’s traded volume of Vir Biotechnology Inc?
What is today’s market capitalisation of Vir Biotechnology Inc?
What is the 52-Week High and Low Range of Vir Biotechnology Inc?
What percentage is Vir Biotechnology Inc down from its 52-Week High?
What percentage is Vir Biotechnology Inc up from its 52-Week Low?
Current Price
$11.2
$0.67
(6.36%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.